Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohko Kitagawa

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Elife|December 31, 2014
Treating type-1 diabetes with an epigenetic drugYohko Kitagawa, Naganari Ohkura
Current Opinion in Immunology|October 25, 2017
Molecular control of regulatory T cell development and functionYohko Kitagawa, Shimon Sakaguchi
European Journal of Immunology|October 29, 2014
Epigenetic control of thymic Treg-cell developmentYohko Kitagawa, Naganari Ohkura, Shimon Sakaguchi
Immunity|March 26, 2013
Development and maintenance of regulatory T cellsNaganari Ohkura, Yohko Kitagawa, Shimon Sakaguchi
Frontiers in Immunology|May 16, 2013
Molecular determinants of regulatory T cell development: the essential roles of epigenetic changesYohko Kitagawa, Naganari Ohkura, Shimon Sakaguchi
Progress in Molecular Biology and Translational Science|November 29, 2015
Transcriptional and Epigenetic Control of Regulatory T Cell DevelopmentYohko Kitagawa, James Badger Wing, Shimon Sakaguchi
Biochemical and Biophysical Research Communications|December 25, 2025
TAF4B knockdown differentially affects erythroid and natural killer cells but not monocytic differentiation from human cord blood HSPCsSaori Nakano, Akira Niwa, Yohko Kitagawa, et al.
Iscience|September 29, 2023
ZEB2 and MEIS1 independently contribute to hematopoiesis via early hematopoietic enhancer activationYohko Kitagawa, Akihiro Ikenaka, Ryohichi Sugimura, et al.
Frontiers in Cell and Developmental Biology|June 5, 2023
A concise Naoya Kase, Yohko Kitagawa, Akihiro Ikenaka, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2021
Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophagesYohko Kitagawa, Yuri Kawasaki, Yuichi Yamasaki, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Elife|December 31, 2014
Treating type-1 diabetes with an epigenetic drugYohko Kitagawa, Naganari Ohkura
Current Opinion in Immunology|October 25, 2017
Molecular control of regulatory T cell development and functionYohko Kitagawa, Shimon Sakaguchi
European Journal of Immunology|October 29, 2014
Epigenetic control of thymic Treg-cell developmentYohko Kitagawa, Naganari Ohkura, Shimon Sakaguchi
Immunity|March 26, 2013
Development and maintenance of regulatory T cellsNaganari Ohkura, Yohko Kitagawa, Shimon Sakaguchi
Frontiers in Immunology|May 16, 2013
Molecular determinants of regulatory T cell development: the essential roles of epigenetic changesYohko Kitagawa, Naganari Ohkura, Shimon Sakaguchi
Progress in Molecular Biology and Translational Science|November 29, 2015
Transcriptional and Epigenetic Control of Regulatory T Cell DevelopmentYohko Kitagawa, James Badger Wing, Shimon Sakaguchi
Biochemical and Biophysical Research Communications|December 25, 2025
TAF4B knockdown differentially affects erythroid and natural killer cells but not monocytic differentiation from human cord blood HSPCsSaori Nakano, Akira Niwa, Yohko Kitagawa, et al.
Iscience|September 29, 2023
ZEB2 and MEIS1 independently contribute to hematopoiesis via early hematopoietic enhancer activationYohko Kitagawa, Akihiro Ikenaka, Ryohichi Sugimura, et al.
Frontiers in Cell and Developmental Biology|June 5, 2023
A concise Naoya Kase, Yohko Kitagawa, Akihiro Ikenaka, et al.
The Journal of Allergy and Clinical Immunology|June 27, 2021
Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophagesYohko Kitagawa, Yuri Kawasaki, Yuichi Yamasaki, et al.
Pageof 3